These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3808322)

  • 1. Cholinergic modulation of human P3 event-related potentials.
    Hammond EJ; Meador KJ; Aung-Din R; Wilder BJ
    Neurology; 1987 Feb; 37(2):346-50. PubMed ID: 3808322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central cholinergic systems and the P3 evoked potential.
    Meador KJ; Loring DW; Adams RJ; Patel BR; Davis HC; Hammond EJ
    Int J Neurosci; 1987 Apr; 33(3-4):199-205. PubMed ID: 3596949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scopolamine impairs memory performance and reduces frontal but not parietal visual P3 amplitude.
    Potter DD; Pickles CD; Roberts RC; Rugg MD
    Biol Psychol; 2000 Feb; 52(1):37-52. PubMed ID: 10686371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo probe of central cholinergic systems.
    Meador KJ; Loring DW; Lee GP; Taylor HS; Hughes DR; Feldman DS
    J Gerontol; 1988 Nov; 43(6):M158-62. PubMed ID: 3183305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic and serotonergic effects on the P3 potential and recent memory.
    Meador KJ; Loring DW; Davis HC; Sethi KD; Patel BR; Adams RJ; Hammond EJ
    J Clin Exp Neuropsychol; 1989 Mar; 11(2):252-60. PubMed ID: 2925834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of physostigmine on the response characteristics of the cat visual evoked potential.
    Rubboli G; Arakawa K; Celesia GG; Peachey NS; Tomoda H
    Doc Ophthalmol; 1993; 84(3):257-65. PubMed ID: 8119105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's disease.
    Bajalan AA; Wright CE; van der Vliet VJ
    J Neurol Neurosurg Psychiatry; 1986 Feb; 49(2):175-82. PubMed ID: 3950635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of physostigmine and scopolamine on recognition memory in monkeys.
    Aigner TG; Mishkin M
    Behav Neural Biol; 1986 Jan; 45(1):81-7. PubMed ID: 3954717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of physostigmine and scopolamine on memory for food caches in the black-capped chickadee.
    Mineau P; Boag PT; Beninger RJ
    Pharmacol Biochem Behav; 1994 Oct; 49(2):363-70. PubMed ID: 7824551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic modulation of preattentive auditory processing in aging.
    Pekkonen E; Jääskeläinen IP; Kaakkola S; Ahveninen J
    Neuroimage; 2005 Aug; 27(2):387-92. PubMed ID: 15921933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Component-specific effects of physostigmine on the cat visual evoked potential.
    Arakawa K; Peachey NS; Celesia G; Rubboli G
    Exp Brain Res; 1993; 95(2):271-6. PubMed ID: 8224052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic anticholinergic and antiserotonergic effects in humans.
    Meador KJ; Loring DW; Hendrix N; Nichols ME; Oberzan R; Moore EE
    J Clin Exp Neuropsychol; 1995 Aug; 17(4):611-21. PubMed ID: 7593479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midlatency auditory evoked responses: differential effects of a cholinergic agonist and antagonist.
    Buchwald JS; Rubinstein EH; Schwafel J; Strandburg RJ
    Electroencephalogr Clin Neurophysiol; 1991; 80(4):303-9. PubMed ID: 1713841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auditory sensory memory and the cholinergic system: implications for Alzheimer's disease.
    Pekkonen E; Hirvonen J; Jääskeläinen IP; Kaakkola S; Huttunen J
    Neuroimage; 2001 Aug; 14(2):376-82. PubMed ID: 11467911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective effects of cholinergic modulation on task performance during selective attention.
    Furey ML; Pietrini P; Haxby JV; Drevets WC
    Neuropsychopharmacology; 2008 Mar; 33(4):913-23. PubMed ID: 17534379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The P3a wave of the auditory event-related potential reveals registration of pitch change during sufentanil anesthesia for cardiac surgery.
    Plourde G; Joffe D; Villemure C; Trahan M
    Anesthesiology; 1993 Mar; 78(3):498-509. PubMed ID: 8457051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Event-related potentials and psychopharmacology. Cholinergic modulation of P300.
    Dierks T; Frölich L; Ihl R; Maurer K
    Pharmacopsychiatry; 1994 Mar; 27(2):72-4. PubMed ID: 7913237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of cholinergic agents on responses recorded from the cat visual cortex and lateral geniculate nucleus dorsalis.
    Arakawa K; Tobimatsu S; Kato M; Kobayashi T
    Electroencephalogr Clin Neurophysiol; 1997 Jul; 104(4):375-80. PubMed ID: 9246076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physostigmine, auditory P300, and Alzheimer's disease.
    Friedman D
    Biol Psychiatry; 1988 Feb; 23(3):321-3. PubMed ID: 3337867
    [No Abstract]   [Full Text] [Related]  

  • 20. Scopolamine disrupts maintenance of attention rather than memory processes.
    Cheal ML
    Behav Neural Biol; 1981 Oct; 33(2):163-87. PubMed ID: 7305812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.